Saturday, July 11, 2026

Drug profile · INN

imp4297

imp4297 is a poly [adp-ribose] polymerase 2 inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — imp4297
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

imp4297 is a poly [adp-ribose] polymerase 2 inhibitor.

Key facts

INN imp4297
Mechanism Poly [ADP-ribose] polymerase 2 inhibitor
Target Poly [ADP-ribose] polymerase 2

Mechanism of action

Poly [ADP-ribose] polymerase 2 inhibitor

Primary target: Poly [ADP-ribose] polymerase 2

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. niraparib tosylate Poly [ADP-ribose] polymerase 2 inhibitor
  2. talazoparib tosylate Poly [ADP-ribose] polymerase-1 inhibitor
  3. niraparib Antineoplastic and immunomodulating agents (L01)
  4. talazoparib Antineoplastic and immunomodulating agents (L01)
  5. niraparib tosilate hydrate Poly [ADP-ribose] polymerase 2 inhibitor
  6. talazoparib tosilate Poly [ADP-ribose] polymerase 2 inhibitor

Frequently asked questions

What is imp4297?

imp4297 is a poly [adp-ribose] polymerase 2 inhibitor.